Ripac New Build – Latest news
LOUNGES 2026 provides valuable input for the Ripac New Build
Heiko Ruediger and Martin Baudis (Ripac-Labor), together with Henrik Wecker (PBM), visited LOUNGES 2026 in [...]
Apr
Faster and more accurate identification of pathogens with new MALDI‑TOF MS technology
RIPAC‑LABOR has recently implemented a new generation of laboratory technology: the MALDI‑TOF MS 8020 from [...]
Apr
[PRESS RELEASE] Dopharma and Ripac-Labor celebrate Topping-Out Ceremony new Production Facility for autogenous vaccines in Potsdam
Raamsdonksveer, Netherlands / Potsdam, Germany, Wednesday 1 April 2026 – In the presence of the [...]
Apr
Introducing Verena Ziethlow, Commercial Coordinator at RIPAC-LABOR
Recently, Dr. Verena Ziethlow joined the RIPAC-LABOR team as Commercial Coordinator. In this newly created [...]
Nov
Follow in real time the progress of the Ripac New Build
Things are moving forward at the Ripac New Build project! Together with our partners we [...]
Sep
Concept design for the Ripac New Build Project has been completed!
𝗔𝗻𝗼𝘁𝗵𝗲𝗿 𝗺𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗿𝗲𝗮𝗰𝗵𝗲𝗱: The concept design for the new RIPAC-LABOR GmbH New Build [...]
Aug
Next milestone in the Ripac-Labor New Build project: ‘the laying of the foundation stone’
Last week, the board members of Dopharma B.V., together with Heiko Rüdiger (CEO RIPAC-LABOR GmbH-Labor), [...]
Jun
Dopharma and Ripac-Labor announce Ground-breaking Ceremony for new Autogenous Vaccine Production Facility in Potsdam
Raamsdonksveer, Netherlands / Potsdam, Germany, 28 February 2025 – The Dopharma Group and its fully owned [...]
Mar
